Back to Search
THOMAS CAMPBELL, MD
MD
Internal Medicine Physician
NPI: 1972506665Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
036042217(IL)
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (20)
Prevalence and risk of residual viremia after ART in low- and middle-income countries: A cross-sectional study.
PMID 34477118·Medicine (Baltimore)·2021
8-other
Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial.
PMID 25681380·Clin Infect Dis·2015
8-other
Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data.
PMID 24979445·Ann Intern Med·2014
4-observational
Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings.
PMID 22936892·PLoS Med·2012
4-observational
Infant outcomes after maternal antiretroviral exposure in resource-limited settings.
PMID 22585772·Pediatrics·2012
3-trial
Quality of life among individuals with HIV starting antiretroviral therapy in diverse resource-limited areas of the world.
PMID 21499794·AIDS Behav·2012
3-trial
Comparisons of anemia, thrombocytopenia, and neutropenia at initiation of HIV antiretroviral therapy in Africa, Asia, and the Americas.
PMID 20961784·Int J Infect Dis·2010
4-observational
Long-term results of initial therapy with abacavir and Lamivudine combined with Efavirenz, Amprenavir/Ritonavir, or Stavudine.
PMID 16967040·J Acquir Immune Defic Syndr·2006
4-observational
Strategies for initiating combination antiretroviral therapy.
PMID 15857194·AIDS Patient Care STDS·2005
4-observational
The ATPase activity of an 'essential' Bacillus subtilis enzyme, YdiB, is required for its cellular function and is modulated by oligomerization.
PMID 19246765·Microbiology (Reading)·2009
8-other
Dimorphic cutaneous manifestation of a toxic eruption due to erlotinib therapy.
PMID 19137770·J Drugs Dermatol·2008
5-case
Clinicopathologic challenge. Gangrenous cellulitis caused by Peptostreptococcus.
PMID 18717855·Int J Dermatol·2008
5-case
Severe exacerbation of rosacea induced by cinnamon supplements.
PMID 18561592·J Drugs Dermatol·2008
5-case
Genetic interaction screens with ordered overexpression and deletion clone sets implicate the Escherichia coli GTPase YjeQ in late ribosome biogenesis.
PMID 18223068·J Bacteriol·2008
8-other
Species-specific visitation and removal of baits for delivery of pharmaceuticals to feral swine.
PMID 17699086·J Wildl Dis·2007
7-preclinical
Isolation of the rstA gene as a multicopy suppressor of YjeE, an essential ATPase of unknown function in Escherichia coli.
PMID 17293428·J Bacteriol·2007
8-other
Magnitude and directional measures of water and Cr(VI) fluxes by passive flux meter.
PMID 17120570·Environ Sci Technol·2006
8-other
The yjeQ gene is required for virulence of Staphylococcus aureus.
PMID 16861682·Infect Immun·2006
7-preclinical
Incidence of sleep disorders in children with presumed normal variant short stature.
PMID 16014141·J Paediatr Child Health·2005
8-other
Characterization of the Bacillus subtilis GTPase YloQ and its role in ribosome function.
PMID 15828870·Biochem J·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 800 AUSTIN ST, SUITE #451 EAST TOWER
EVANSTON, IL 60202 - Phone
- (847) 316-6611
Quick Facts
- NPI
- 1972506665
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile